u-STOP LVAD Bleed
This is a Phase I, single ascending dose, first in human, open-label, non-controlled, dose-escalation trial that will investigate intravenous infusions of Umbilical cord lining stem cells (UCLSCs) in Left Ventricular Assist Device (LVAD)鈥�
- Investigator
- Mustafa M Ahmed
- Status
- Accepting Candidates
- Ages
- 18 Years - 80 Years
- Sexes
- All
Study for Evaluating the EVAHEART?2 LVAS: the COMPETENCE Trial (COMPETENCE)
This is a prospective, multi-center, unblinded, randomized, controlled, and non-inferiority study comparing the EVA2 LVAS to the most recent magnetically levitated centrifugal LVAS (HM3 LVAS).
- Investigator
- Mustafa M Ahmed
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All